Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients

Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients

Abstract Background The common inflammatory disease multiple sclerosis (MS) is a disease of the central nervous system. For more than 25 years autologous hematopoietic stem cell transplantation (AHSCT) has been used to treat MS. It has been shown to be highly effective in suppressing inflammatory ac...

Full description

Bibliographic Details
Main Authors: Aina Vaivade, Anna Wiberg, Payam Emami Khoonsari, Henrik Carlsson, Stephanie Herman, Asma Al-Grety, Eva Freyhult, Ulla Olsson-Strömberg, Joachim Burman, Kim Kultima
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Lipids in Health and Disease
Subjects:
Lipidomics
Metabolomics
Autologous hematopoietic stem cell transplantation
Relapsing-remitting multiple sclerosis
Ceramides
Online Access:https://doi.org/10.1186/s12944-023-01863-7

Internet

https://doi.org/10.1186/s12944-023-01863-7

Similar Items